Generex announces publication of Ebola vaccine white paper by Antigen Express
Generex announced that its wholly owned subsidiary, Antigen Express, has issued a white paper outlining the advantages of its Ii-Key technology in the development of an effective Ebola vaccine. The Antigen Express vaccines can be generated quickly to meet the demands of new threats. October 21, 2014